# Alteplase Compared to Tenecteplase in Patients With Acute Ischemic Stroke

Study · id `cardio:ct-nct03889249` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03889249](<https://clinicaltrials.gov/study/NCT03889249>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03889249

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1600 participants.

## Technical summary

Registry record NCT03889249. Randomized; single masking; primary purpose treatment. Start 2019-12-10 (actual); primary completion 2022-04-26 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 1600 participants (enrolled count; ClinicalTrials.gov record NCT03889249, source copy `cardio:ctgov-nct03889249-2023-05-12`, retrieved 2026-10-26)
- Started: 2019-12-10 (actual) (ClinicalTrials.gov record NCT03889249, source copy `cardio:ctgov-nct03889249-2023-05-12`, retrieved 2026-10-26)
- Primary completion: 2022-04-26 (actual) (ClinicalTrials.gov record NCT03889249, source copy `cardio:ctgov-nct03889249-2023-05-12`, retrieved 2026-10-26)
- Completion: 2023-04-30 (actual) (ClinicalTrials.gov record NCT03889249, source copy `cardio:ctgov-nct03889249-2023-05-12`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT03889249, source copy `cardio:ctgov-nct03889249-2023-05-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03889249-2023-05-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Alteplase Compared to Tenecteplase in Patients With Acute Ischemic Stroke
- Acronym: AcT
- Condition: Stroke, Acute
- Condition: Thromboses, Intracranial
- Intervention (Drug): Tenecteplase
- Intervention (Drug): Alteplase
- Lead sponsor: University of Calgary
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Tenecteplase (`cardio:tenecteplase`)
- Registry lists this organization as the lead sponsor: University of Calgary (`cardio:org-university-of-calgary`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of Time to Thrombolysis on Clinical Outcomes in Patients With Acute Ischemic Stroke Treated With Tenecteplase Compared to Alteplase: Analysis From the AcT Randomized Controlled Trial (`cardio:pubmed-37800372`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Quality of Life After Intravenous Thrombolysis for Acute Ischemic Stroke: Results From the AcT Randomized Controlled Trial (`cardio:pubmed-38275116`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Safety, Functional Disability, Healthcare Utilization, and Quality-of-Life Outcomes in Elderly Receiving Alteplase and Tenecteplase: A Secondary Analysis From the AcT Trial (`cardio:pubmed-40123483`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of thrombolysis type on the efficacy of aspiration versus stent retriever first line thrombectomy: results from the AcT trial (`cardio:pubmed-39379314`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Predictors and Consequences of Serious Adverse Events in Patients Treated With Thrombolysis: A Prespecified Secondary Analysis of the AcT Trial (`cardio:pubmed-42261967`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Evaluating Differential Item Functioning in EQ-5D-5L in Acute Ischemic Stroke: Evidence From the ACT Trial (`cardio:pubmed-42488952`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 23defc05e2d16964956d1f089e09646d9eda5d2b1c3ccb9b3553d77e1a577d6a
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
